The global hormonal contraceptive market was valued at USD 16.73 billion in 2023 and is projected to grow from USD 17.45 billion in 2024 to reach USD 24.60 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 4.4% during the forecast period from 2024 to 2032.
Hormonal contraceptive
The global pharmacovigilance market was valued at USD 7.45 billion in 2023 and is poised for significant growth, projected to increase from USD 7.95 billion in 2024 to USD 13.60 billion by 2032, registering a compound annual growth rate (CAGR) of 6.9% during the 2024–2032 forecast period. This
The global cold plasma market was valued at USD 2,293.15 million in 2024 and is projected to grow from USD 2,632.47 million in 2025 to USD 9,232.20 million by 2034, registering a compound annual growth rate (CAGR) of 15.0% during the forecast period from 2025 to 2034. This exponential growth traject
The global digital therapeutics (DTx) market, valued at USD 6.89 billion in 2023, is on a steep growth trajectory. It is projected to grow from USD 8.91 billion in 2024 to an impressive USD 70.63 billion by 2032, expanding at a robust compound annual growth rate (CAGR) of 29.5% from 2024 to 2032.
The global C-reactive protein (CRP) testing market, valued at USD 1,834.23 million in 2023, is poised for steady growth, projected to reach USD 2,331.22 million by 2032, expanding at a compound annual growth rate (CAGR) of 2.7% from 2023 to 2032. This growth is driven by the rising prevalence of chr